{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:04:39Z","timestamp":1787241879480,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.clinph.2021.02.397","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T21:54:02Z","timestamp":1617832442000},"page":"1407-1415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sensory and motor axonal excitability testing in early diabetic neuropathy"],"prefix":"10.1016","volume":"132","author":[{"given":"A.G.","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gylfadottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Itani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kr\u00f8ig\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.B.","family":"Finnerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sindrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tankisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2021.02.397_b0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.diabres.2010.11.008","article-title":"Altered nerve excitability in subclinical\/early diabetic neuropathy: Evidence for early neurovascular process in diabetes mellitus?","volume":"91","author":"Bae","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clinph.2021.02.397_b0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C","article-title":"Threshold tracking techniques in the study of human peripheral nerve","volume":"21","author":"Bostock","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2021.02.397_b0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/dmrr.2397","article-title":"Whither pathogenetic treatments for diabetic polyneuropathy?","volume":"29","author":"Boulton","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clinph.2021.02.397_b0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.clinph.2021.02.397_b0025","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2337\/dc19-2277","article-title":"Metabolic factors, lifestyle habits, and possible polyneuropathy in early type 2 diabetes: A nationwide study of 5,249 patients in the Danish centre for strategic research in type 2 diabetes (DD2) Cohort","volume":"43","author":"Christensen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinph.2021.02.397_b0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/dmrr.1226","article-title":"Diabetic polyneuropathies: Update on research definition, diagnostic criteria and estimation of severity","volume":"27","author":"Dyck","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.clinph.2021.02.397_b0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.clinph.2021.02.397_b0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinph.2021.02.397_b0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mus.26303","article-title":"Tibial nerve axonal excitability in type 1 diabetes mellitus","volume":"59","author":"Gencpinar","year":"2019","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.clinph.2021.02.397_b0050","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/j.pain.0000000000001744","article-title":"Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes","volume":"161","author":"Gylfadottir","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.clinph.2021.02.397_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14469","article-title":"Diagnosis and prevalence of diabetic polyneuropathy: A cross-sectional study of Danish patients with type 2 diabetes","author":"Gylfadottir","year":"2020","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.clinph.2021.02.397_b0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.clinph.2017.11.015","article-title":"Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivation","volume":"129","author":"Heide","year":"2018","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.clinph.2021.02.397_b0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clinph.2019.07.023","article-title":"Measurement of axonal excitability: consensus guidelines","volume":"131","author":"Kiernan","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2021.02.397_b0070","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/brain\/awh476","article-title":"Altered nerve excitability properties in established diabetic neuropathy","volume":"128","author":"Krishnan","year":"2005","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.clinph.2021.02.397_b0075","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.clinph.2019.08.003","article-title":"Detection of early motor involvement in diabetic polyneuropathy using a novel MUNE method - MScanFit MUNE","volume":"130","author":"Kristensen","year":"2019","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"10.1016\/j.clinph.2021.02.397_b0080","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.clinph.2020.07.017","article-title":"MScanFit motor unit number estimation and muscle velocity recovery cycle recordings in diabetic polyneuropathy","volume":"131","author":"Kristensen","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2021.02.397_b0085","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.clinph.2015.11.047","article-title":"In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes","volume":"127","author":"Kwai","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2021.02.397_b0090","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/mus.25274","article-title":"Association between glycemic variability and peripheral nerve dysfunction in type 1 diabetes","volume":"54","author":"Kwai","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2021.02.397_b0095","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2337\/dc12-1310","article-title":"Effects of axonal ion channel dysfunction on quality of life in type 2 diabetes","volume":"36","author":"Kwai","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinph.2021.02.397_b0100","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.clinph.2004.12.019","article-title":"Axonal potassium conductance and glycemic control in human diabetic nerves","volume":"116","author":"Misawa","year":"2005","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2021.02.397_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S31104","article-title":"The Danish national type 2 diabetes cohort - the DD2 study","volume":"4","author":"S\u00f8rensen","year":"2012","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.clinph.2021.02.397_b0110","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2337\/db11-1509","article-title":"Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes","volume":"61","author":"Sung","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.clinph.2021.02.397_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171223","article-title":"Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy","volume":"12","author":"Sung","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.clinph.2021.02.397_b0120","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.clinph.2005.04.003","article-title":"Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines","volume":"116","author":"Tankisi","year":"2005","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2021.02.397_b0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cnp.2019.10.005","article-title":"Evidence-based recommendations for examination and diagnostic strategies of polyneuropathy electrodiagnosis","volume":"4","author":"Tankisi","year":"2019","journal-title":"Clin Neurophysiol Pract"},{"issue":"10","key":"10.1016\/j.clinph.2021.02.397_b0130","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138824572100496X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138824572100496X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:04:44Z","timestamp":1761393884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138824572100496X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S138824572100496X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2021.02.397","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sensory and motor axonal excitability testing in early diabetic neuropathy","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2021.02.397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}